BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2906514)

  • 1. Do alpha 2-agonists inhibit sympathetic transmitter secretion in part by depressing a Ca2+ component of the nerve impulse 'upstream' of varicosities?
    Stjärne C; Stjärne E; Msghina M
    Acta Physiol Scand; 1988 Aug; 133(4):591-2. PubMed ID: 2906514
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that alpha 2-agonists may inhibit sympathetic transmitter secretion by an effect 'upstream' of varicosities.
    Stjärne L; Stjärne E
    Acta Physiol Scand; 1988 Jul; 133(3):433-4. PubMed ID: 2906511
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropeptide Y may inhibit sympathetic transmitter secretion by an effect 'upstream' of varicosities.
    Stjärne L; Stjärne E; Mshgina M; Lundberg JM
    Acta Physiol Scand; 1988 Dec; 134(4):577-8. PubMed ID: 2907962
    [No Abstract]   [Full Text] [Related]  

  • 4. Some pharmacological applications of an extracellular recording method to study secretion of a sympathetic co-transmitter, presumably ATP.
    Stjärne L; Stjärne E
    Acta Physiol Scand; 1989 Mar; 135(3):227-39. PubMed ID: 2564719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that action potential-induced Ca2+ influx is necessary but not sufficient to release transmitter from sympathetic nerve terminals.
    Msghina M; Stjärne E; Astrand P; Stjärne L
    Acta Physiol Scand; 1990 Feb; 138(2):239-40. PubMed ID: 1969221
    [No Abstract]   [Full Text] [Related]  

  • 6. Basic features of an extracellular recording method to study secretion of a sympathetic co-transmitter, presumably ATP.
    Stjärne L; Stjärne E
    Acta Physiol Scand; 1989 Mar; 135(3):217-26. PubMed ID: 2564718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature dependence of 'local' and 'upstream' regulation of sympathetic transmitter secretion in mouse vas deferens.
    Stjärne L; Msghina M; Stjärne E; Tanaka E
    Acta Physiol Scand; 1989 Oct; 137(2):311-2. PubMed ID: 2575843
    [No Abstract]   [Full Text] [Related]  

  • 8. K+ channel-blocking agents may augment sympathetic transmitter secretion by action 'upstream' of varicosities.
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1989 Sep; 137(1):151-2. PubMed ID: 2801154
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chronic clonidine treatment on transmitter release from sympathetic varicosities of the guinea-pig vas deferens.
    Knight D; Cunnane TC; Lavidis NA
    Br J Pharmacol; 2001 Dec; 134(7):1480-6. PubMed ID: 11724754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is 'upstream' control of sympathetic transmitter release dependent on the length of varicosity strings?
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1989 Oct; 137(2):313-4. PubMed ID: 2575844
    [No Abstract]   [Full Text] [Related]  

  • 11. K+ and Ca2+ channel blocking agents increase or decrease stimulus-evoked but not spontaneous quantal transmitter release in sympathetic nerve terminals.
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1990 Feb; 138(2):235-7. PubMed ID: 2156406
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cyclic AMP the intra-axonal messenger 'X' mediating 'upstream' control of sympathetic transmitter secretion?
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1989 Aug; 136(4):617-8. PubMed ID: 2571237
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens.
    Karunanithi S; Lavidis NA
    Br J Pharmacol; 2001 Jan; 132(2):403-10. PubMed ID: 11159688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual variations in potency of alpha,beta-methylene ATP as inhibitor of the excitatory junction current in mouse vas deferens caused by sympathetic nerve stimulation.
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1989 Oct; 137(2):315-6. PubMed ID: 2575845
    [No Abstract]   [Full Text] [Related]  

  • 16. Potassium channel blocking agents induce occasional spontaneous action potentials and multiquantal ATP release in sympathetic nerve terminals.
    Msghina M; Stjärne E; Stjärne L
    Acta Physiol Scand; 1989 Apr; 135(4):593-4. PubMed ID: 2544080
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency dependent intermittency and ionic basis of impulse conduction in postganglionic sympathetic fibres of guinea-pig vas deferens.
    Cunnane TC; Stjärne L
    Neuroscience; 1984 Jan; 11(1):211-29. PubMed ID: 6324028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors.
    Smith AB; Cunnane TC
    Br J Pharmacol; 1998 Jan; 123(2):167-72. PubMed ID: 9489603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electrophysiological study on the effect of neuropeptide Y on sympathetic neurotransmission in guinea pig vas deferens.
    Cheung DW; Dukkipati R
    J Pharmacol Exp Ther; 1991 Jun; 257(3):979-83. PubMed ID: 1675292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.
    Jackson VM; Cunnane TC
    Br J Pharmacol; 2002 Apr; 135(8):1845-50. PubMed ID: 11959786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.